Dugbe virus ovarian tumour domain interferes with ubiquitin/ISG15-regulated innate immune cell signalling

Journal of General Virology

Volumn 94, Issue PART2, 2013, Pages 298-307

  Bakshi, S ^a,b   Holzer, B ^b   Bridgen, A ^a,c   McMullan, G ^a   Quinn, D G ^a   Baron, M D ^b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c Croft Dhu   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON STIMULATED GENE 15 PROTEIN; JANUS KINASE; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DUGBE VIRUS; EMBRYO; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; INNATE IMMUNITY; NAIRO VIRUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALS; CATALYTIC DOMAIN; CELL LINE; HUMANS; HYDROLYSIS; IMMUNE EVASION; IMMUNITY, INNATE; NAIROVIRUS; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; UBIQUITIN; VIRAL PROTEINS;

DUGBE VIRUS; NAIROVIRUS;

EID: 84872440579     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.048322-0     Document Type: Article

References (43)

1. Akutsu, M., Ye, Y., Virdee, S., Chin, J. W. & Komander, D. (2011). Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc Natl Acad Sci U S A 108, 2228-2233.
2. Andersson, I., Karlberg, H., Mousavi-Jazi, M., Martínez-Sobrido, L., Weber, F. & Mirazimi, A. (2008). Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J Med Virol 80, 1397-1404.
3. Bergeron, E., Albariño, C. G., Khristova, M. L. & Nichol, S. T. (2010). Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function. J Virol 84, 216-226.
4. Bhoj, V. G. & Chen, Z. J. (2009). Ubiquitylation in innate and adaptive immunity. Nature 458, 430-437.
5. Blomstrom, D. C., Fahey, D., Kutny, R., Korant, B. D. & Knight, E., Jr (1986). Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem 261, 8811-8816.
6. Boyd, A., Fazakerley, J. K. & Bridgen, A. (2006). Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice. J Gen Virol 87, 2005-2009.
7. Bridgen, A., Dalrymple, D. A. & Elliott, R. M. (2002). Dugbe nairovirus S segment: correction of published sequence and comparison of five isolates. Virology 294, 364-371.
8. Burt, F. J., Spencer, D. C., Leman, P. A., Patterson, B. & Swanepoel, R. (1996). Investigation of tick-borne viruses as pathogens of humans in South Africa and evidence of Dugbe virus infection in a patient with prolonged thrombocytopenia. Epidemiol Infect 116, 353-361.
9. Causey, O. R. (1970). Supplement to the catalogue of arthropod-borne viruses. Am J Trop Med Hyg 19, 1123-1124.
10. Coates, D. M. & Sweet, C. (1990). Studies on the pathogenicity of a nairovirus, Dugbe virus, in normal and immunosuppressed mice. J Gen Virol 71, 325-332.
11. Crabtree, M. B., Sang, R. & Miller, B. R. (2009). Kupe virus, a new virus in the family Bunyaviridae, genus nairovirus, Kenya. Emerg Infect Dis 15, 147-154.
12. David-West, T. S. & Porterfield, J. S. (1974). Dugbe virus: a tick-borne arbovirus from Nigeria. J Gen Virol 23, 297-307.
13. Enesa, K., Zakkar, M., Chaudhury, H., Luong, A., Rawlinson, L., Mason, J. C., Haskard, D. O., Dean, J. L. & Evans, P. C. (2008). NF-κB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J Biol Chem 283, 7036-7045.
14. Ergonul, O. (2006). Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6, 203-214.
15. Farrell, P. J., Broeze, R. J. & Lengyel, P. (1979). Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 279, 523-525.
16. Frias-Staheli, N., Giannakopoulos, N. V., Kikkert, M., Taylor, S. L., Bridgen, A., Paragas, J., Richt, J. A., Rowland, R. R., Schmaljohn, C. S. & other authors (2007). Ovarian tumor domain-containing viral proteases evade ubiquitin-and ISG15-dependent innate immune responses. Cell Host Microbe 2, 404-416.
17. Haas, A. L., Ahrens, P., Bright, P. M. & Ankel, H. (1987). Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 262, 11315-11323.
18. Habjan, M., Andersson, I., Klingstrom, J., Schumann, M., Martin, A., Zimmermann, P., Wagner, V., Pichlmair, A., Schneider, U. & other authors (2008). Processing of genome 59 termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3, e2032.
19. Harty, R. N., Pitha, P. M. & Okumura, A. (2009). Antiviral activity of innate immune protein ISG15. J Innate Immun 1, 397-404.
20. Hayden, M. S., West, A. P. & Ghosh, S. (2006). NF-kB and the immune response. Oncogene 25, 6758-6780.
21. Holzer, B., Bakshi, S., Bridgen, A. & Baron, M. D. (2011). Inhibition of interferon induction and action by the nairovirus Nairobi sheep disease virus/Ganjam virus. PLoS ONE 6, e28594.
22. James, T. W., Frias-Staheli, N., Bacik, J. P., Levingston Macleod, J. M., Khajehpour, M., García-Sastre, A. & Mark, B. L. (2011). Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc Natl Acad Sci U S A 108, 2222-2227.
23. Jeon, Y. J., Yoo, H. M. & Chung, C. H. (2010). ISG15 and immune diseases. Biochim Biophys Acta 1802, 485-496.
24. Killip, M. J., Young, D. F., Ross, C. S., Chen, S., Goodbourn, S. & Randall, R. E. (2011). Failure to activate the IFN-b promoter by a paramyxovirus lacking an interferon antagonist. Virology 415, 39-46.
25. Kim, M. J., Hwang, S. Y., Imaizumi, T. & Yoo, J. Y. (2008). Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 82, 1474-1483.
26. Lai, C., Struckhoff, J. J., Schneider, J., Martinez-Sobrido, L., Wolff, T., García-Sastre, A., Zhang, D. E. & Lenschow, D. J. (2009). Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 83, 1147-1151.
27. Lenschow, D. J., Giannakopoulos, N. V., Gunn, L. J., Johnston, C., O'Guin, A. K., Schmidt, R. E., Levine, B. & Virgin, H. W., IV (2005). Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79, 13974-13983.
28. Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt, R. E. & other authors (2007). IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104, 1371-1376.
29. Lu, G., Reinert, J. T., Pitha-Rowe, I., Okumura, A., Kellum, M., Knobeloch, K. P., Hassel, B. & Pitha, P. M. (2006). ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisy-le-grand) 52, 29-41.
30. Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J. & Zhang, D. E. (2002). UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 277, 9976-9981.
31. Malakhov, M. P., Kim, K. I., Malakhova, O. A., Jacobs, B. S., Borden, E. C. & Zhang, D. E. (2003). High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 278, 16608-16613.
32. Malakhova, O. A., Yan, M., Malakhov, M. P., Yuan, Y., Ritchie, K. J., Kim, K. I., Peterson, L. F., Shuai, K. & Zhang, D. E. (2003). Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev 17, 455-460.
33. Marczinke, B. I. & Nichol, S. T. (2002). Nairobi sheep disease virus, an important tick-borne pathogen of sheep and goats in Africa, is also present in Asia. Virology 303, 146-151.
34. Minakawa, M., Sone, T., Takeuchi, T. & Yokosawa, H. (2008). Regulation of the nuclear factor (NF)-κB pathway by ISGylation. Biol Pharm Bull 31, 2223-2227.
35. Nanda, S. K. & Baron, M. D. (2006). Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. J Virol 80, 7555-7568.
36. Peyrefitte, C. N., Perret, M., Garcia, S., Rodrigues, R., Bagnaud, A., Lacote, S., Crance, J. M., Vernet, G., Garin, D. & other authors (2010). Differential activation profiles of Crimean-Congo hemorrhagic fever virus-and Dugbe virus-infected antigen-presenting cells. J Gen Virol 91, 189-198.
37. Platanias, L. C. (2005). Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 5, 375-386.
38. Sang, R., Onyango, C., Gachoya, J., Mabinda, E., Konongoi, S., Ofula, V., Dunster, L., Okoth, F., Coldren, R. & other authors (2006). Tickborne arbovirus surveillance in market livestock, Nairobi, Kenya. Emerg Infect Dis 12, 1074-1080.
39. Schmaljohn, C. S. & Nichol, S. T. (2007). Bunyaviridae. In Fields Virology, 5th edn, pp. 1742-1789. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams and Wilkins.
40. Tamatani, M., Che, Y. H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., Mizuno, T. & Tohyama, M. (1999). Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons. J Biol Chem 274, 8531-8538.
41. van Kasteren, P. B., Beugeling, C., Ninaber, D. K., Frias-Staheli, N., van Boheemen, S., García-Sastre, A., Snijder, E. J. & Kikkert, M. (2012). Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling. J Virol 86, 773-785.
42. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R. & other authors (2004). Deubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699.
43. Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S. & Krug, R. M. (2005). Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102, 10200-10205.